Wound Care Market Reports
Deep research that delivers actionable intelligence is at the heart of what we do at iData Research. Our wound care market research has helped clients make a wide range of critical decisions, such as product development, mergers and acquisitions, allocation of marketing resources and much more. We uncover all of the relevant wound care industry trends, providing the information clients need to determine their best possible strategies to increase market share.
Industry Trends In the static compression market, poor circulation in the extremities can lead to venous leg ulcers and other conditions that cannot heal properly. Fluid can also accumulate in the leg, a condition known as edema. These conditions can be treated by wearing compression bandages, Unna boots or graduated compression stockings. Graduated compression stockings
Suturing is one of the most common and longstanding practices in medicine, so despite the increase in other wound closure devices, the suture market is expected to continue growing. However, the improved simplicity and ease-of-use of staplers and skin closure systems will result in sutures share of the wound closure market declining marginally by 2025.
As the number of surgeries performed continues to increase year over year in the U.S., the need for medical sealants will grow accordingly. Over the forecast period, plant-based synthetics will grow in popularity, due to the potential risk of viral disease transmission inherent in plasma-derived products. In addition, price erosion in the synthetic market will
In this market, there are several products approved for multiple indications and surgical specialties, which creates greater growth potential in the market. Gelatin-based hemostats represented the smallest segment in 2018, and will continue to do so through 2025. There is little innovation in this segment and the market is moving towards alternative choices. Hemostats, also
There has been an increase in education on the benefits of anti-adhesive products. Adhesions can cause chronic pain, bowel obstruction and infertility, and it is more expensive to repair an adhesion once it has occurred then to prevent it by using an anti-adhesive product. Some surgeons believe that excellent surgical technique can prevent adhesions from
Overall, the European wound care market was valued at 4.38 billion in 2019. This is expected to increase over the forecast period at a compound annual growth rate (CAGR) of 2.7% to reach 5.27 billion. The majority of segments included in the wound and tissue management market are witnessing declining average selling prices. Companies are
Industry Trends There has been increased product innovation throughout the wound and tissue management market in both the European and the U.S. market. Companies are attempting to create products that are easier for physicians to use, fight infection, and take less time for wound closure. Although these products can be more expensive, a smaller quantity
Industry Trends With the introduction of the Affordable Care Act, a shift has occurred which moved care out of acute care centers, due to the cost burden it places on the U.S. medical system. Home care is the most economical place to deliver care; therefore, the lowest reimbursement rate is associated with it. Reimbursement rates
Industry Trends Traditional dressings have a much lower ASP than advanced dressings and, wherever possible, traditional dressings are preferred over higher-ASP moist and antimicrobial dressings. These products will always be a mainstay in the wound care market. All segments of this market will exhibit low growth, as the market is mature. Gauze makes up a
The full report suite on the U.S. market for wound and tissue management includes wound closure devices; traditional, moist, antimicrobial, interactive wound dressings; non-adherent contact layers; hemostats; tissue sealants; anti-adhesion; negative pressure wound therapy; and static and dynamic compression therapy.
The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs, often as a result of injury during surgery. These adhesions can be formed during any type of surgery, including gynecological, abdominal, orthopedic, cardiac and neurological procedures.
Hemostats, also known as anti-hemorrhagic agents are substances that promote hemostasis, the process which causes bleeding to stop. There are a number of topical hemostats used in surgeries. Topical hemostats are suitable for minor bleeding and oozing blood from injured capillaries and venules. Physiologic hemostasis occurs with vascular constriction and is a complex process in which blood changes from a fluid to a solid state in order to control tissue damage and bleeding. Thrombin binds to platelets and becomes activated. They activate fibrinogen into fibrin. The fibrin monomers combine to create fibrin structures that coagulate open arteries. Platelets aggregate at the injury site (the surgical incision) to form a temporary plug.
Tissue sealants and glues are used in certain surgical procedures and for some types of bleeding to seal the edges of tissue together; thus, tissue sealants can also be used to seal blood vessels, causing hemostasis. Even though some products are indicated only for tissue sealing, they can also be used off-label as a hemostat as well.
The Japanese market for wound and tissue management includes any device that treats wounds to the skin, dermal layers and adjacent subcutaneous tissues in addition to devices that manage trauma to tissue and blood vessels during surgery. Wound management devices treat external wounds, while dressings, compression and negative pressure wound therapy aid the bodys innate ability to heal skin, surgical and chronic wounds. Devices used for tissue management help stop bleeding, close surgical incisions and prevent the scarring of internal tissue. Wound closure devices hold together tissue long enough for the body to develop scar tissue. Wound and tissue management devices are essential to individuals who lack a properly functioning circulatory system and who have a decreased ability to induce blood coagulation or the inflammatory response.
The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at
minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs,
often as a result of injury during surgery. These adhesions can be formed during any type of surgery,
including gynecological, abdominal, orthopedic, cardiac and neurological procedures.
A number of topical hemostats are used in surgeries. Topical hemostats are suitable for minor bleeding and oozing blood from injured capillaries and venules. Physiologic hemostasis occurs with vascular constriction and is a complex process in which blood changes from a fluid to a solid state in order to control tissue damage and bleeding.